Sustained delivery of gemcitabine via in situ injectable mussel-inspired hydrogels for the local therapy of pancreatic cancer

A desirable therapeutic strategy has been designed and optimized for the localized drug delivery system in vitro and in vivo against pancreatic cancer cells, having the highest possible deceleration of tumor growth with the minimum use of doses.